Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Small Bone Innovations raises $108 million to launch STAR ankle: Orthopedic firm raises $108 million in a "Series D" private placement of preferred stock to help support the ongoing U.S. launch of its STAR total ankle replacement system. STAR became the first motion-preserving, mobile-bearing ankle replacement device available in the United States following PMA approval May 27 (1"The Gray Sheet" June 1, 2009). Announced June 30, the "Series D" financing closed in April; it follows a $36 million "Series C" funding round in 2008. Aside from supporting the STAR launch, proceeds from the offerings helped to complete the 2008 acquisition of the STAR technology from German firm Waldemar Link, as well as to retire a $20 million credit facility, according to the company
You may also be interested in...
STAR Becomes First Mobile-Bearing Ankle Approved In U.S.
Small Bone Innovations (SBi) hopes its STAR total ankle replacement system will be the catalyst for a shift in ankle procedures away from the fusion surgery standard toward a market dominated by joint replacement. But the barriers in the still-limited ankle replacement space are not trivial
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.